For: | Yan LN, Wang W, Li B, Lu SC, Wen TF, Lin QY, Zeng Y, Cheng NS, Zhao JC, Dai YM. Single-dose daclizumab induction therapy in patients with liver transplantation. World J Gastroenterol 2003; 9(8): 1881-1883 [PMID: 12918145 DOI: 10.3748/wjg.v9.i8.1881] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v9/i8/1881.htm |
Number | Citing Articles |
1 |
Marty T. Sellers, Brendan M. McGuire, Silke V. Haustein, John S. Bynon, Sharon L. Hunt, Devin E. Eckhoff. Two-dose Daclizumab Induction Therapy in 209 Liver Transplants: A Single-Center Analysis. Transplantation 2004; 78(8): 1212 doi: 10.1097/01.TP.0000138100.72757.BA
|
2 |
J. Kobashigawa, K. David, J. Morris, A.H. Chu, B.J. Steffen, V.P. Gotz, R.D. Gordon. Daclizumab is Associated With Decreased Rejection and No Increased Mortality in Cardiac Transplant Patients Receiving MMF, Cyclosporine, and Corticosteroids. Transplantation Proceedings 2005; 37(2): 1333 doi: 10.1016/j.transproceed.2004.12.135
|
3 |
D.W. Orr, B.C. Portmann, A.S. Knisely, S. Stoll, M. Rela, P. Muiesan, M.J. Bowles, N.D. Heaton, J.G. O’Grady, M.A. Heneghan. Anti-Interleukin 2 Receptor Antibodies and Mycophenolate Mofetil for Treatment of Steroid-Resistant Rejection in Adult Liver Transplantation. Transplantation Proceedings 2005; 37(10): 4373 doi: 10.1016/j.transproceed.2005.10.022
|
4 |
Christian Toso, Andrew L. Mason, Norman M. Kneteman. Liver Transplantation. 2009; : 19 doi: 10.1007/978-1-60327-028-1_2
|
5 |
Laura Cecilioni, Lucy Dagher, Andrew Burroughs. Evidence‐based Gastroenterology and Hepatology. 2004; : 545 doi: 10.1002/9780470987025.ch36
|
6 |
Christian Toso, A.M. James Shapiro. Endocrine Manifestations of Systemic Autoimmune Diseases. Handbook of Systemic Autoimmune Diseases 2008; 9: 275 doi: 10.1016/S1571-5078(07)00225-5
|
7 |
Joan Figueras, Martin Prieto, Angel Bernardos, Antoni Rimola, Francisco Suarez, Jorge Ortiz de Urbina, Valentin Cuervas-Mons, Manuel de la Mata. Daclizumab induction and maintenance steroid-free immunosuppression with mycophenolate mofetil and tacrolimus to prevent acute rejection of hepatic allografts. Transplant International 2006; 19(8): 641 doi: 10.1111/j.1432-2277.2006.00326.x
|
8 |
John C Mullen, Emily J Kuurstra, Antigone Oreopoulos, Michael J Bentley, Shaohua Wang. A randomized controlled trial of daclizumab versus anti-thymocyte globulin induction for heart transplantation. Transplantation Research 2014; 3(1) doi: 10.1186/2047-1440-3-14
|